This site is intended for Healthcare professionals only.

Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa


Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa

Gene testing company Illumina won a $26.7 million jury verdict in a U.S. lawsuit accusing rival Ariosa Diagnostics, a subsidiary of Roche Holdings AG, of using patented prenatal testing technology without authorization.

A federal jury in San Francisco said Ariosa’s Harmony non-invasive prenatal test kits infringed on two Illumina patents.

Illumina and Ariosa compete in the growing market for non-invasive prenatal tests, which screen for chromosomal conditions like Down syndrome.

San Diego, California-based Illumina had sought more than $100 million in damages.

The jury rejected a counterclaim by Ariosa that Illumina had breached a contract between the companies by bringing the lawsuit. Ariosa had sought $88 million in damages from Illumina on that counterclaim.

Illumina and Ariosa did not immediately respond to requests for comment.

Roche acquired San Jose, California-based Ariosa for $625 million in January 2015.

(Reporting by Jan Wolfe; Editing by Cynthia Osterman and Richard Chang)



Source: Reuters
0 comment(s) on Illumina wins 26.7 million dollars in patent fight with Roche unit Ariosa

Share your Opinion Disclaimer

Sort by: Newest | Oldest | Most Voted